Skip to content

Robotic vs. Freehand Corrective Surgery for Pediatric Scoliosis

Multicenter, Prospective, Partially Randomized, Controlled Trial of Robotic-guided vs. Freehand Corrective Surgery for Pediatric Scoliosis

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02084264
Acronym
PEDSCOLI
Enrollment
272
Registered
2014-03-11
Start date
2014-10-31
Completion date
2019-07-08
Last updated
2019-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scoliosis

Keywords

Adolescent Idiopathic Scoliosis, Pediatric Scoliosis

Brief summary

To compare the accuracy and feasibility, curvature correction and clinical outcomes of pedicle screw instrumentation with versus without robotic guidance, in pediatric and adolescent scoliosis patients

Interventions

None listed

Sponsors

Mazor Robotics
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
10 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

1. Pediatric/adolescent patients (age 10 to 21 years), undergoing a primary surgery for the correction of a scoliotic curve of 40 degrees or greater 2. Patient capable of complying with study requirements 3. Signed informed consent by patient

Exclusion criteria

1. Scheuermann's disease 2. Infection or malignancy 3. Primary abnormalities of bones (e.g. osteogenesis imperfecta) 4. Primary muscle diseases, such as muscular dystrophy 5. Neurologic diseases (e.g. Charcot-Marie Tooth, Guillain-Barre syndrome, cerebral palsy, spina bifida, or neurofibroma) 6. Spinal cord abnormalities with any neurologic symptoms or signs 7. Spinal cord lesions requiring neurosurgical interventions, such as hydromyelia 8. Patients who have participated in a research study involving an investigational product in the 12 weeks prior to surgery 9. Patients requiring anterior release or instrumentation 10. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study. 11. Pregnancy 12. Patient cannot follow study protocol, for any reason 13. Patient cannot or will not sign informed consent

Design outcomes

Primary

MeasureTime frameDescription
Revision surgeries1 year post-surgeryAll cause revisions, including medical and surgical complications.

Secondary

MeasureTime frameDescription
Neuromonitoring eventsDay of surgery
Hypoplastic pediclesDay of surgery\<4 mm in diameter
Improvement of radiographic and health-related quality of life metricsup to 10 years post-operativepost-operative radiographs and SRS22 questionnaire
Length of convalescencewithin 2 years of surgeryLength of hospital stay, destination at discharge, time to return to normal activities
Clinical performance of instrumentation techniqueDay of surgeryinstrumentation time per screw, total surgery time, excluding: exposure and closure time, Surgeon-specific surgical techniques that impact surgery time
Radiation ExposureDay of surgeryReading of exposure in seconds (and KvP, if available) from C-arm or other imaging system used in the operating room.
Ratio of executed vs. planned screwsDay of surgeryNumber of screws planned to be robotically inserted and manually inserted instead, and cause.
Pedicle screw instrumentation accuracyWithin 1 year of surgery, if indicated by surgeon and clinically necessaryAccuracy will be quantified in millimeters and scored using the Gertzbein-Robbins classification, based on post-operative CTs that are clinically necessary for the management of the patient.
Surgical complicationsWithin first year from day of surgeryImplant-related durotomy, infection requiring surgery, excessive blood loss, air emboli, new neural deficits, implant failure
Clinical Outcomes as measured on plain radiographs2 yearsCurvature correction and shoulder balance

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026